SONOMA PHARMACEUTICALS, INC. (SNOA)

1.31 -1.50% (-0.02)

Over 5Y: -98.9%

2026-08-28
50 100 150
2021 2022 2023 2024 2025 2026

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q2 '22 — Revenue: 3.7M Q2 '22 — Operating Cash Flow: -1.3M Q2 '22 — Free Cash Flow: -1.3M Q2 '22 — Net Income: -100K Q3 '22 — Revenue: 2.9M Q3 '22 — Operating Cash Flow: -326K Q3 '22 — Free Cash Flow: -327K Q3 '22 — Net Income: -944K Q4 '22 — Revenue: 2.3M Q4 '22 — Operating Cash Flow: -1.4M Q4 '22 — Free Cash Flow: -1.5M Q4 '22 — Net Income: -2.9M Q1 '23 — Revenue: 4M Q1 '23 — Operating Cash Flow: -1.5M Q1 '23 — Free Cash Flow: -1.6M Q1 '23 — Net Income: -887K Q2 '23 — Revenue: 3.3M Q2 '23 — Operating Cash Flow: -1.8M Q2 '23 — Free Cash Flow: -1.9M Q2 '23 — Net Income: -1M Q3 '23 — Revenue: 2.9M Q3 '23 — Operating Cash Flow: -348K Q3 '23 — Free Cash Flow: -379K Q3 '23 — Net Income: -1.9M Q4 '23 — Revenue: 3M Q4 '23 — Operating Cash Flow: -2.4M Q4 '23 — Free Cash Flow: -2.6M Q4 '23 — Net Income: -1.3M Q1 '24 — Revenue: 3.4M Q1 '24 — Operating Cash Flow: -215K Q1 '24 — Free Cash Flow: -232K Q1 '24 — Net Income: -1.4M Q2 '24 — Revenue: 2.7M Q2 '24 — Operating Cash Flow: -1.2M Q2 '24 — Free Cash Flow: -1.2M Q2 '24 — Net Income: -1.5M Q3 '24 — Revenue: 3.1M Q3 '24 — Operating Cash Flow: -1.1M Q3 '24 — Free Cash Flow: -1.1M Q3 '24 — Net Income: -866K Q4 '24 — Revenue: 3.4M Q4 '24 — Operating Cash Flow: 152K Q4 '24 — Net Income: -1.1M Q1 '25 — Revenue: 3.4M Q1 '25 — Operating Cash Flow: -912K Q1 '25 — Free Cash Flow: -917K Q1 '25 — Net Income: -1.1M Q2 '25 — Revenue: 3.6M Q2 '25 — Operating Cash Flow: 354K Q2 '25 — Free Cash Flow: 328K Q2 '25 — Net Income: -610K Q3 '25 — Revenue: 3.6M Q3 '25 — Operating Cash Flow: 565K Q3 '25 — Free Cash Flow: 563K Q3 '25 — Net Income: -928K Q4 '25 — Revenue: 3.8M Q4 '25 — Operating Cash Flow: -95K Q4 '25 — Free Cash Flow: -142K Q4 '25 — Net Income: -776K Q1 '26 — Revenue: 4M Q1 '26 — Operating Cash Flow: -2M Q1 '26 — Free Cash Flow: -2.1M Q1 '26 — Net Income: -1.2M Q2 '26 — Revenue: 5.6M Q2 '26 — Operating Cash Flow: -635K Q2 '26 — Free Cash Flow: -645K Q2 '26 — Net Income: -534K Q3 '26 — Revenue: 4.3M Q3 '26 — Operating Cash Flow: -764K Q3 '26 — Free Cash Flow: -811K Q3 '26 — Net Income: -819K Q4 '26 — Revenue: 5.6M Q4 '26 — Operating Cash Flow: -519K Q4 '26 — Free Cash Flow: -548K Q4 '26 — Net Income: -581K Q1 '27 — Revenue: 6.4M Q1 '27 — Operating Cash Flow: -649K Q1 '27 — Free Cash Flow: -651K Q1 '27 — Net Income: -330K -2M 0 2M 4M 6M 8M
Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.4
OE margin -13.3%
Oper. margin -6.4%
ROIC -88.4%
Accruals 1.7%
Gross margin 38.9%
FCF margin -12.1%
OCF margin -11.7%
Profit margin -10.3%
ROA -12.5%
ROCE -11.1%
ROE -34.3%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

2.1
RPO / sales 0.013×
RPO growth —
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Interest cover -234.3×
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 2.3×
Cash runway 2.0 yr
F-score 2.2 pts
Cash / Debt —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.6
Sales CAGR 4Y +11.5%
Sales/sh Y/Y +8.3%
Sales Q/Q +59.6%
Shares change +35.7%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.